Telix Pharmaceuticals Ltd

NEW
FRA:T3X (Australia)   Ordinary Shares
€ 8.81 +0.069 (+0.79%) Jul 28
At Loss
P/B:
7.86
Market Cap:
€ 3.01B ($ 3.45B)
Enterprise V:
€ 3.30B ($ 3.78B)
Volume:
365.00
Avg Vol (2M):
707.00
Trade In:

Telix Pharmaceuticals Ltd (FRA:T3X) Dividend

Telix Pharmaceuticals Ltd (FRA:T3X) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:T3X Dividend

Does Telix Pharmaceuticals Ltd (FRA:T3X) pay a dividend?

Telix Pharmaceuticals Ltd (FRA:T3X) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Telix Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Telix Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -2.3% over the past 3 years.

What are dividend-paying alternatives to Telix Pharmaceuticals Ltd?

For dividend-paying alternatives in Telix Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.